Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries
Maimaiti, Namaitijiang, Ahmed, Zafar, Isa, Zaleha Md., Ghazi, Hasanain F. and Aljunid, Syed M., (2013). Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries. ScienceDirect, 2(2), 260-263
Document type:
Article
Collection:
-
Related Links Link Description 
http://iigh.unu.edu/wp-content/uploads/2013/11/Clinical_-Burden_of_Invasive_P... Hyperlink
http://dx.doi.org/10.1016/j.vhri.2013.07.003 Full text from publisher -
Sub-type Journal article Author Maimaiti, Namaitijiang
Ahmed, Zafar
Isa, Zaleha Md.
Ghazi, Hasanain F.
Aljunid, Syed M.Title Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries Appearing in ScienceDirect Volume 2 Issue No. 2 Publication Date 2013-02-01 Place of Publication Amsterdam Publisher Elsevier Start page 260 End page 263 Language English Abstract Objective: To measure the clinical burden of invasive pneumococcal disease (IPD) in selected developing countries. Methods: This is an extensive literature review of published articles on IPD in selected developing countries from East Asia, South Asia, Middle East, sub-Saharan Africa, and Latin America. We reviewed all the articles retrieved from the knowledge bases that were published between the years 2000 and 2010. Results: After applying the inclusion, exclusion, and quality criteria, the comprehensive review of the literature yielded 10 articles with data for pneumococcal meningitis, septicemia / bacteremia, and pneumonia. These selected articles were from 10 developing countries from ?ve different regions. Out of the 10 selected articles, 8 have a detailed discussion on IPD, one of them has detailed discussion on bacteremia and meningitis, and another one has discussed pneumococcal bacteremia. Out of these 10 articles, only 5 articles discussed the case-fatalityratio (CFR). In our article review, the incidence of IPD ranged from less than 5/100,000 to 416/100,000 population and the CFR ranged from 12.2% to 80% in the developing countries. Conclusions: There view demonstrated that the clinical burden of IPD was high in the developing countries. The incidence of IPD and CFR varies from region to region and from country to country. The IPD burden was highest in sub-Saharan African countries followed by South Asian countries. The CFR was low in high-income countries than in low-income countries. Copyright Holder International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Copyright Year 2013 Copyright type All rights reserved DOI 10.1016/j.vhri.2013.07.003 -
Citation counts 
Cited 0 times in Scopus
Article
Search Google Scholar
Access Statistics: 701 Abstract Views - Detailed Statistics Created: Wed, 11 Jun 2014, 16:20:25 JST